A mouse model involving the human papillomavirus type-16 oncogenes develops cervical cancers by lesional stages analogous to those in humans. In this study the angiogenic phenotype was characterized, revealing intense angiogenesis in high-grade cervical intraepithelial neoplasias (CIN-3) and carcinomas. MMP-9, a proangiogenic protease implicated in mobilization of VEGF, appeared in the stroma concomitant with the angiogenic switch, expressed by infiltrating macrophages, similar to what has been observed in humans. Preclinical trials sought to target MMP-9 and angiogenesis with a prototypical MMP inhibitor and with a bisphosphonate, zoledronic acid (ZA), revealing both to be antiangiogenic, producing effects comparable to a Mmp9 gene KO in impairing angiogenic switching, progression of premalignant lesions, and tumor growth. ZA therapy increased neoplastic epithelial and endothelial cell apoptosis without affecting hyperproliferation, indicating that ZA was not antimitotic. The analyses implicated cellular and molecular targets of ZA’s actions: ZA suppressed MMP-9 expression by infiltrating macrophages and inhibited metalloprotease activity, reducing association of VEGF with its receptor on angiogenic endothelial cells. Given its track record in clinical use with limited toxicity, ZA holds promise as an “unconventional” MMP-9 inhibitor for antiangiogenic therapy of cervical cancer and potentially for additional cancers and other diseases where MMP-9 expression by infiltrating macrophages is evident.
Enrico Giraudo, Masahiro Inoue, Douglas Hanahan
Title and authors | Publication | Year |
---|---|---|
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes the vasculature
Federica Maione, Fabiola Molla, Claudia Meda, Roberto Latini, Lorena Zentilin, Mauro Giacca, Giorgio Seano, Guido Serini, Federico Bussolino, Enrico Giraudo |
Journal of Clinical Investigation | 2009 |
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
M Coscia, E Quaglino, M Iezzi, C Curcio, F Pantaleoni, C Riganti, I Holen, H Mönkkönen, M Boccadoro, G Forni, P Musiani, A Bosia, F Cavallo, M Massaia |
Journal of Cellular and Molecular Medicine | 2009 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Revisiting the seed and soil in cancer metastasis
M Mendoza, C Khanna |
The International Journal of Biochemistry & Cell Biology | 2009 |
High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors
LS Ojalvo, W King, D Cox, JW Pollard |
The American Journal of Pathology | 2009 |
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts
AC Hirbe, AJ Roelofs, DH Floyd, H Deng, SN Becker, LG Lanigan, AJ Apicelli, Z Xu, JL Prior, MC Eagleton, D Piwnica-Worms, MJ Rogers, K Weilbaecher |
Bone | 2009 |
Magnetic resonance imaging defines cervicovaginal anatomy, cancer, and VEGF trap antiangiogenic efficacy in estrogen-treated K14-HPV16 transgenic mice
JR Garbow, AC Santeford, JR Anderson, JA Engelbach, JM Arbeit |
Cancer research | 2009 |
Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature
GO Ahn, JM Brown |
Angiogenesis | 2009 |
The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in ApcMin/+mice
Y Kawasaki, S Tsuji, K Muroya, S Furukawa, Y Shibata, M Okuno, S Ohwada, T Akiyama |
EMBO reports | 2009 |
Type I interferons inhibit the generation of tumor-associated macrophages
L U’Ren, A Guth, D Kamstock, S Dow |
Cancer Immunology, Immunotherapy | 2009 |
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
DG DeNardo, JB Barreto, P Andreu, L Vasquez, D Tawfik, N Kolhatkar, LM Coussens |
Cancer Cell | 2009 |
Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines.
Yagui-Beltrán A, Coussens LM, Jablons DM |
US oncology | 2009 |
Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: Experimental models and clinical perspectives
Ahn GO, Brown JM |
Cell cycle (Georgetown, Tex.) | 2009 |
The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors
Lipton A, Uzzo R, Amato RJ, Ellis GK, Hakimian B, Roodman GD, Smith MR |
Journal of the National Comprehensive Cancer Network : JNCCN | 2009 |
When neighbourhood matters: tumour microenvironment.
Pérez-Moreno M |
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2009 |